Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.

Second Quarter 2015 Financial Results

Genmab will report its Second Quarter 2015 financial results after market close on August 11. An investor conference call to discuss the results will be held at 6PM CET / 12PM EST on August 11. To join the call by phone, dial one of hte folloiwng numbers and ask for the Genmab conference call: +45 3832 2869 in Denmark, +44 20 3427 1914 in the UK or +1 646 254 3363 in the US. Click here to listen to the webcast.


news email 150x110

Get the Latest Genmab News

Subscribe to our email alert mailing list to ensure you receive the latest news from Genmab as it happens. Visit http://ir.genmab.com/alerts.cfm and fill out the form to subscribe.

 

GenmabTech.com

Our Technologies Explained

Learn about Genmab’s proprietary cutting edge technologies, the DuoBody® and HexaBody® platforms at our new technology website GenmabTech.com